Glimisave M1 750 Tab

GLIMISAVE M1 750 Tablet

Name

Brand Name: Glimisave M1 750 Tablet (also referred to as Glimisave M1 750 Tablet PR in some contexts). Common Names (Active Ingredients): Glimepiride and Metformin.

Composition

Each Glimisave M1 750 Tablet contains:

• Glimepiride: 1 mg
• Metformin Hydrochloride: 750 mg (often in a sustained-release formulation)

Uses

GLIMISAVE M1 750 Tablet is an anti-diabetic medication primarily used in adults for the treatment of Type 2 Diabetes Mellitus. It is prescribed when blood sugar levels are not adequately controlled by diet and exercise alone, or by a single antidiabetic agent.

It works by:

• Glimepiride: Stimulating the pancreas to release more insulin, thereby lowering blood sugar levels.
• Metformin: Reducing the amount of glucose produced by the liver, delaying sugar absorption from the intestines, and improving the body's sensitivity to insulin.

This dual action helps to improve glycemic control and prevent serious diabetes-related complications such as kidney damage, eye problems, nerve issues, and loss of limbs. It may also be used off-label for the management of insulin resistance associated with Polycystic Ovary Syndrome (PCOS).

Dosage and Administration

GLIMISAVE M1 750 Tablet should be taken orally, typically once or twice daily, as prescribed by a physician. It is generally recommended to take the tablet with meals to minimize gastrointestinal side effects. The tablet should be swallowed whole with a glass of water and not be cut, chewed, or broken. It is crucial to take the medicine consistently at the same time each day to maintain steady blood glucose levels. The dosage is individualized based on the patient's medical condition, blood sugar levels, and response to treatment.

Side Effects

Common Side Effects:

• Stomach pain, nausea, vomiting, diarrhea
• Metallic taste, taste disturbance
• Headache, dizziness, weakness, fatigue
• Loss of appetite
• Hypoglycemia (low blood sugar), with symptoms including sweating, dizziness, palpitations, shivering, intense thirst, dry mouth, and frequent urination
• Skin rash, itching

Serious Side Effects (Rare):

• Lactic acidosis (accumulation of lactic acid), which can manifest as muscle pain or weakness, severe dizziness, extreme tiredness, feeling cold in arms and legs, difficulty breathing, persistent nausea, vomiting, or stomach pain, and a slow heart rate.
• Inflammation of the liver, potentially leading to jaundice (yellowing of skin or eyes).
• Severe allergic reactions, including skin rash, hives, increased sensitivity to sun, inflammation of blood vessels, difficulty breathing, or a fall in blood pressure.
• Vitamin B12 deficiency (with long-term use).

Precautions

• Contraindications: Do not take GLIMISAVE M1 750 Tablet if allergic to Glimepiride, Metformin, or any other components, or if there is a sulfa (sulfonamide) allergy. It is contraindicated in patients with Type 1 Diabetes Mellitus, diabetic ketoacidosis, diabetic coma, severe kidney or liver disease, or acute heart problems.
• Pregnancy and Breastfeeding: Not recommended during pregnancy as it may harm the unborn baby. Avoid breastfeeding as the medicine may pass into breast milk and cause adverse effects in the baby.
• Alcohol Consumption: Avoid alcohol as it significantly increases the risk of lactic acidosis and hypoglycemia.
• Driving and Operating Machinery: May decrease alertness; exercise caution when driving or operating machinery.
• Medical Conditions: Inform your doctor about any existing kidney or liver problems, heart disease, or other medical conditions. Regular monitoring of kidney and liver function tests may be advised.
• Hypoglycemia Management: Always carry a fast-acting source of glucose (e.g., candies, glucose biscuits, fruit juice) to manage episodes of low blood sugar.
• Drug Interactions: Inform your doctor about all other medications, supplements, or herbal products being taken to avoid potential interactions.

Storage

Store GLIMISAVE M1 750 Tablet in a cool and dry place, away from direct sunlight, at room temperature (between 10ºC to 25ºC or below 30ºC). Keep it out of reach and sight of children and pets.

GLIMISAVE M1 750 TAB by ERIS PHARMACEUTICALS is a medication used to manage Type 2 Diabetes Mellitus. It combines two active ingredients, Glimepiride and Metformin, to help control blood sugar levels.

What is GLIMISAVE M1 750 TAB used for?

GLIMISAVE M1 750 TAB is used to treat type 2 diabetes mellitus in adults, especially when diet and exercise alone, or a single antidiabetic agent, are not sufficient to control blood sugar levels. It helps to lower blood sugar and reduce the risk of diabetes-related complications such as kidney damage, eye problems, and nerve issues.

How does GLIMISAVE M1 750 TAB work?

This medicine contains Glimepiride and Metformin, which work together to regulate blood sugar. Glimepiride stimulates the pancreas to produce more insulin, a hormone that helps remove sugar from the blood. Metformin works by reducing the amount of sugar produced by the liver, delaying sugar absorption from the intestines, and increasing the body's sensitivity to insulin, allowing muscle cells to use sugar more effectively.

What is the usual dosage for GLIMISAVE M1 750 TAB?

The dosage of GLIMISAVE M1 750 TAB is determined by your doctor based on your individual medical condition, blood sugar levels, and response to treatment. It is typically taken once or twice daily, ideally with meals, to help prevent stomach discomfort. It's crucial to take the medicine consistently at the same time each day to maintain steady medication levels.

What are the possible side effects of GLIMISAVE M1 750 TAB?

Common side effects may include stomach pain, nausea, diarrhea, vomiting, headache, or a metallic taste. Some people may also experience low blood sugar (hypoglycemia), especially if meals are skipped, alcohol is consumed, or with excessive exercise. A serious but rare side effect is lactic acidosis, which involves a buildup of lactic acid in the body. If side effects persist or worsen, consult your doctor.

Is GLIMISAVE M1 750 TAB safe during pregnancy or breastfeeding?

GLIMISAVE M1 750 TAB is generally not recommended during pregnancy as it may harm the unborn baby. Similarly, it is considered unsafe to use during breastfeeding because it may pass into breast milk and potentially cause adverse effects in the baby. Always consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Can GLIMISAVE M1 750 TAB be taken with other medications?

It is important to inform your doctor about all medications, supplements, or herbals you are currently taking or plan to take to avoid potential drug interactions. Some medicines can affect how GLIMISAVE M1 750 TAB works, or GLIMISAVE M1 750 TAB can reduce the effectiveness of other medicines.

What precautions should be taken with GLIMISAVE M1 750 TAB?

Do not take GLIMISAVE M1 750 TAB if you are allergic to its components, have type 1 diabetes mellitus, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor if you have liver or kidney problems, low blood sugar, or circulation problems. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis and low blood sugar. This medicine may decrease alertness, so exercise caution when driving.

What happens if a dose of GLIMISAVE M1 750 TAB is missed?

If you miss a dose, take it as soon as you remember. However, if your next dose is approaching, skip the missed dose and continue with your regular schedule. Do not double the dose to make up for a missed one. Missing a dose can lead to high blood sugar levels.

How should GLIMISAVE M1 750 TAB be stored?

GLIMISAVE M1 750 TAB should be stored in a cool and dry place, away from direct sunlight. Keep it out of the reach and sight of children. It should be stored at temperatures between 10ºC to 25ºC or below 30ºC.